nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—Clobetasol propionate—psoriasis	0.101	0.255	CrCtD
Fludrocortisone—Fluocinolone Acetonide—psoriasis	0.0785	0.198	CrCtD
Fludrocortisone—Hydrocortisone—psoriasis	0.0396	0.1	CrCtD
Fludrocortisone—Dexamethasone—psoriasis	0.0368	0.093	CrCtD
Fludrocortisone—Betamethasone—psoriasis	0.0368	0.093	CrCtD
Fludrocortisone—Triamcinolone—psoriasis	0.036	0.0908	CrCtD
Fludrocortisone—NR3C1—Clobetasol propionate—psoriasis	0.0359	0.148	CbGbCtD
Fludrocortisone—Prednisone—psoriasis	0.0341	0.0862	CrCtD
Fludrocortisone—Prednisolone—psoriasis	0.0333	0.0841	CrCtD
Fludrocortisone—NR3C2—Betamethasone—psoriasis	0.0282	0.116	CbGbCtD
Fludrocortisone—NR3C2—Prednisolone—psoriasis	0.0278	0.115	CbGbCtD
Fludrocortisone—NR3C1—Fluocinolone Acetonide—psoriasis	0.0272	0.112	CbGbCtD
Fludrocortisone—NR3C1—Beclomethasone—psoriasis	0.0272	0.112	CbGbCtD
Fludrocortisone—NR3C1—Fluocinonide—psoriasis	0.0272	0.112	CbGbCtD
Fludrocortisone—NR3C2—Dexamethasone—psoriasis	0.0164	0.0677	CbGbCtD
Fludrocortisone—NR3C1—Triamcinolone—psoriasis	0.0108	0.0448	CbGbCtD
Fludrocortisone—NR3C1—Betamethasone—psoriasis	0.0093	0.0384	CbGbCtD
Fludrocortisone—NR3C1—Prednisolone—psoriasis	0.00917	0.0379	CbGbCtD
Fludrocortisone—NR3C1—Hydrocortisone—psoriasis	0.0087	0.0359	CbGbCtD
Fludrocortisone—NR3C1—Prednisone—psoriasis	0.00866	0.0358	CbGbCtD
Fludrocortisone—NR3C1—Dexamethasone—psoriasis	0.00541	0.0223	CbGbCtD
Fludrocortisone—Fluocinolone Acetonide—Clobetasol propionate—psoriasis	0.00314	0.0114	CrCrCtD
Fludrocortisone—Fluoxymesterone—Clobetasol propionate—psoriasis	0.00305	0.0111	CrCrCtD
Fludrocortisone—Amcinonide—Clobetasol propionate—psoriasis	0.00305	0.0111	CrCrCtD
Fludrocortisone—Flurandrenolide—Fluocinonide—psoriasis	0.00303	0.011	CrCrCtD
Fludrocortisone—Desonide—Clobetasol propionate—psoriasis	0.00297	0.0108	CrCrCtD
Fludrocortisone—Prednisone—Clobetasol propionate—psoriasis	0.00297	0.0108	CrCrCtD
Fludrocortisone—Diflorasone—Clobetasol propionate—psoriasis	0.00297	0.0108	CrCrCtD
Fludrocortisone—Flurandrenolide—Fluocinolone Acetonide—psoriasis	0.00294	0.0106	CrCrCtD
Fludrocortisone—Hydrocortamate—Beclomethasone—psoriasis	0.00283	0.0102	CrCrCtD
Fludrocortisone—Desoximetasone—Clobetasol propionate—psoriasis	0.00283	0.0102	CrCrCtD
Fludrocortisone—Loteprednol—Clobetasol propionate—psoriasis	0.00276	0.01	CrCrCtD
Fludrocortisone—Mometasone—Clobetasol propionate—psoriasis	0.00276	0.01	CrCrCtD
Fludrocortisone—Fluprednidene Acetate—Clobetasol propionate—psoriasis	0.00276	0.01	CrCrCtD
Fludrocortisone—Triamcinolone—Clobetasol propionate—psoriasis	0.00276	0.01	CrCrCtD
Fludrocortisone—Fluorometholone—Clobetasol propionate—psoriasis	0.00276	0.01	CrCrCtD
Fludrocortisone—Dexamethasone—Clobetasol propionate—psoriasis	0.0027	0.00977	CrCrCtD
Fludrocortisone—Betamethasone—Clobetasol propionate—psoriasis	0.0027	0.00977	CrCrCtD
Fludrocortisone—Methylprednisolone—Clobetasol propionate—psoriasis	0.00258	0.00935	CrCrCtD
Fludrocortisone—Prednisolone—Clobetasol propionate—psoriasis	0.00253	0.00915	CrCrCtD
Fludrocortisone—Fluocinolone Acetonide—Fluocinonide—psoriasis	0.00251	0.0091	CrCrCtD
Fludrocortisone—Fluocinolone Acetonide—Beclomethasone—psoriasis	0.00251	0.0091	CrCrCtD
Fludrocortisone—Eplerenone—Hydrocortisone—psoriasis	0.0025	0.00905	CrCrCtD
Fludrocortisone—Amcinonide—Fluocinonide—psoriasis	0.00245	0.00886	CrCrCtD
Fludrocortisone—Amcinonide—Beclomethasone—psoriasis	0.00245	0.00886	CrCrCtD
Fludrocortisone—Diflorasone—Beclomethasone—psoriasis	0.00238	0.00863	CrCrCtD
Fludrocortisone—Desonide—Beclomethasone—psoriasis	0.00238	0.00863	CrCrCtD
Fludrocortisone—Diflorasone—Fluocinonide—psoriasis	0.00238	0.00863	CrCrCtD
Fludrocortisone—Clobetasol propionate—Fluocinonide—psoriasis	0.00238	0.00863	CrCrCtD
Fludrocortisone—Clobetasol propionate—Beclomethasone—psoriasis	0.00238	0.00863	CrCrCtD
Fludrocortisone—Desonide—Fluocinonide—psoriasis	0.00238	0.00863	CrCrCtD
Fludrocortisone—Amcinonide—Fluocinolone Acetonide—psoriasis	0.00238	0.00861	CrCrCtD
Fludrocortisone—Desonide—Fluocinolone Acetonide—psoriasis	0.00232	0.00838	CrCrCtD
Fludrocortisone—Diflorasone—Fluocinolone Acetonide—psoriasis	0.00232	0.00838	CrCrCtD
Fludrocortisone—Clobetasol propionate—Fluocinolone Acetonide—psoriasis	0.00232	0.00838	CrCrCtD
Fludrocortisone—Desoximetasone—Beclomethasone—psoriasis	0.00227	0.00821	CrCrCtD
Fludrocortisone—Desoximetasone—Fluocinonide—psoriasis	0.00227	0.00821	CrCrCtD
Fludrocortisone—Fluorometholone—Fluocinonide—psoriasis	0.00221	0.00801	CrCrCtD
Fludrocortisone—Fluprednidene Acetate—Beclomethasone—psoriasis	0.00221	0.00801	CrCrCtD
Fludrocortisone—Loteprednol—Beclomethasone—psoriasis	0.00221	0.00801	CrCrCtD
Fludrocortisone—Triamcinolone—Beclomethasone—psoriasis	0.00221	0.00801	CrCrCtD
Fludrocortisone—Mometasone—Beclomethasone—psoriasis	0.00221	0.00801	CrCrCtD
Fludrocortisone—Fluprednidene Acetate—Fluocinonide—psoriasis	0.00221	0.00801	CrCrCtD
Fludrocortisone—Mometasone—Fluocinonide—psoriasis	0.00221	0.00801	CrCrCtD
Fludrocortisone—Triamcinolone—Fluocinonide—psoriasis	0.00221	0.00801	CrCrCtD
Fludrocortisone—Fluorometholone—Beclomethasone—psoriasis	0.00221	0.00801	CrCrCtD
Fludrocortisone—Desoximetasone—Fluocinolone Acetonide—psoriasis	0.0022	0.00797	CrCrCtD
Fludrocortisone—Dexamethasone—Fluocinonide—psoriasis	0.00216	0.00783	CrCrCtD
Fludrocortisone—Dexamethasone—Beclomethasone—psoriasis	0.00216	0.00783	CrCrCtD
Fludrocortisone—Betamethasone—Fluocinonide—psoriasis	0.00216	0.00783	CrCrCtD
Fludrocortisone—Betamethasone—Beclomethasone—psoriasis	0.00216	0.00783	CrCrCtD
Fludrocortisone—Triamcinolone—Fluocinolone Acetonide—psoriasis	0.00215	0.00779	CrCrCtD
Fludrocortisone—Mometasone—Fluocinolone Acetonide—psoriasis	0.00215	0.00779	CrCrCtD
Fludrocortisone—Fluprednidene Acetate—Fluocinolone Acetonide—psoriasis	0.00215	0.00779	CrCrCtD
Fludrocortisone—Fluorometholone—Fluocinolone Acetonide—psoriasis	0.00215	0.00779	CrCrCtD
Fludrocortisone—Betamethasone—Fluocinolone Acetonide—psoriasis	0.0021	0.00761	CrCrCtD
Fludrocortisone—Dexamethasone—Fluocinolone Acetonide—psoriasis	0.0021	0.00761	CrCrCtD
Fludrocortisone—Methylprednisolone—Fluocinonide—psoriasis	0.00207	0.00749	CrCrCtD
Fludrocortisone—Prednisolone—Beclomethasone—psoriasis	0.00202	0.00733	CrCrCtD
Fludrocortisone—Methylprednisolone—Fluocinolone Acetonide—psoriasis	0.00201	0.00728	CrCrCtD
Fludrocortisone—Dydrogesterone—Hydrocortisone—psoriasis	0.00198	0.00719	CrCrCtD
Fludrocortisone—Prednisolone—Fluocinolone Acetonide—psoriasis	0.00197	0.00712	CrCrCtD
Fludrocortisone—Potassium Canrenoate—Hydrocortisone—psoriasis	0.00189	0.00685	CrCrCtD
Fludrocortisone—Spironolactone—Hydrocortisone—psoriasis	0.00189	0.00685	CrCrCtD
Fludrocortisone—Megestrol acetate—Hydrocortisone—psoriasis	0.00173	0.00626	CrCrCtD
Fludrocortisone—Potassium Canrenoate—Prednisone—psoriasis	0.00163	0.0059	CrCrCtD
Fludrocortisone—Potassium Canrenoate—Prednisolone—psoriasis	0.00159	0.00575	CrCrCtD
Fludrocortisone—Medroxyprogesterone Acetate—Hydrocortisone—psoriasis	0.00154	0.00557	CrCrCtD
Fludrocortisone—Flurandrenolide—Hydrocortisone—psoriasis	0.00148	0.00538	CrCrCtD
Fludrocortisone—Hydrocortamate—Hydrocortisone—psoriasis	0.00139	0.00503	CrCrCtD
Fludrocortisone—Flurandrenolide—Dexamethasone—psoriasis	0.00138	0.00499	CrCrCtD
Fludrocortisone—Flurandrenolide—Betamethasone—psoriasis	0.00138	0.00499	CrCrCtD
Fludrocortisone—Cortisone acetate—Hydrocortisone—psoriasis	0.00135	0.00487	CrCrCtD
Fludrocortisone—Flurandrenolide—Prednisolone—psoriasis	0.00125	0.00452	CrCrCtD
Fludrocortisone—Fluoxymesterone—Hydrocortisone—psoriasis	0.0012	0.00435	CrCrCtD
Fludrocortisone—Hydrocortamate—Prednisone—psoriasis	0.0012	0.00433	CrCrCtD
Fludrocortisone—Desonide—Hydrocortisone—psoriasis	0.00117	0.00423	CrCrCtD
Fludrocortisone—Prednisone—Hydrocortisone—psoriasis	0.00117	0.00423	CrCrCtD
Fludrocortisone—Progesterone—Hydrocortisone—psoriasis	0.00117	0.00423	CrCrCtD
Fludrocortisone—Testosterone Propionate—Hydrocortisone—psoriasis	0.00117	0.00423	CrCrCtD
Fludrocortisone—Hydrocortamate—Prednisolone—psoriasis	0.00117	0.00423	CrCrCtD
Fludrocortisone—Cortisone acetate—Prednisone—psoriasis	0.00116	0.0042	CrCrCtD
Fludrocortisone—Fluocinolone Acetonide—Dexamethasone—psoriasis	0.00115	0.00415	CrCrCtD
Fludrocortisone—Fluocinolone Acetonide—Betamethasone—psoriasis	0.00115	0.00415	CrCrCtD
Fludrocortisone—Methyltestosterone—Hydrocortisone—psoriasis	0.00114	0.00413	CrCrCtD
Fludrocortisone—Cortisone acetate—Prednisolone—psoriasis	0.00113	0.0041	CrCrCtD
Fludrocortisone—Fluocinolone Acetonide—Triamcinolone—psoriasis	0.00112	0.00405	CrCrCtD
Fludrocortisone—Fluoxymesterone—Betamethasone—psoriasis	0.00111	0.00404	CrCrCtD
Fludrocortisone—Fluoxymesterone—Dexamethasone—psoriasis	0.00111	0.00404	CrCrCtD
Fludrocortisone—Amcinonide—Dexamethasone—psoriasis	0.00111	0.00404	CrCrCtD
Fludrocortisone—Amcinonide—Betamethasone—psoriasis	0.00111	0.00404	CrCrCtD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—REN—psoriasis	0.00111	0.14	CbGpPWpGaD
Fludrocortisone—Desoximetasone—Hydrocortisone—psoriasis	0.00111	0.00403	CrCrCtD
Fludrocortisone—Amcinonide—Triamcinolone—psoriasis	0.00109	0.00394	CrCrCtD
Fludrocortisone—Fluoxymesterone—Triamcinolone—psoriasis	0.00109	0.00394	CrCrCtD
Fludrocortisone—Triamcinolone—Hydrocortisone—psoriasis	0.00109	0.00393	CrCrCtD
Fludrocortisone—Fluprednidene Acetate—Hydrocortisone—psoriasis	0.00109	0.00393	CrCrCtD
Fludrocortisone—Loteprednol—Hydrocortisone—psoriasis	0.00109	0.00393	CrCrCtD
Fludrocortisone—Fluorometholone—Hydrocortisone—psoriasis	0.00109	0.00393	CrCrCtD
Fludrocortisone—Mometasone—Hydrocortisone—psoriasis	0.00109	0.00393	CrCrCtD
Fludrocortisone—Clobetasol propionate—Betamethasone—psoriasis	0.00109	0.00393	CrCrCtD
Fludrocortisone—Desonide—Betamethasone—psoriasis	0.00109	0.00393	CrCrCtD
Fludrocortisone—Clobetasol propionate—Dexamethasone—psoriasis	0.00109	0.00393	CrCrCtD
Fludrocortisone—Desonide—Dexamethasone—psoriasis	0.00109	0.00393	CrCrCtD
Fludrocortisone—Diflorasone—Dexamethasone—psoriasis	0.00109	0.00393	CrCrCtD
Fludrocortisone—Diflorasone—Betamethasone—psoriasis	0.00109	0.00393	CrCrCtD
Fludrocortisone—Prednisone—Betamethasone—psoriasis	0.00109	0.00393	CrCrCtD
Fludrocortisone—Prednisone—Dexamethasone—psoriasis	0.00109	0.00393	CrCrCtD
Fludrocortisone—Dexamethasone—Hydrocortisone—psoriasis	0.00106	0.00384	CrCrCtD
Fludrocortisone—Betamethasone—Hydrocortisone—psoriasis	0.00106	0.00384	CrCrCtD
Fludrocortisone—Clobetasol propionate—Triamcinolone—psoriasis	0.00106	0.00384	CrCrCtD
Fludrocortisone—Diflorasone—Triamcinolone—psoriasis	0.00106	0.00384	CrCrCtD
Fludrocortisone—Desonide—Triamcinolone—psoriasis	0.00106	0.00384	CrCrCtD
Fludrocortisone—Prednisone—Triamcinolone—psoriasis	0.00106	0.00384	CrCrCtD
Fludrocortisone—Fluocinolone Acetonide—Prednisolone—psoriasis	0.00104	0.00375	CrCrCtD
Fludrocortisone—Amcinonide—Prednisone—psoriasis	0.00103	0.00374	CrCrCtD
Fludrocortisone—Desoximetasone—Dexamethasone—psoriasis	0.00103	0.00374	CrCrCtD
Fludrocortisone—Desoximetasone—Betamethasone—psoriasis	0.00103	0.00374	CrCrCtD
Fludrocortisone—Methylprednisolone—Hydrocortisone—psoriasis	0.00102	0.00367	CrCrCtD
Fludrocortisone—Testosterone—Hydrocortisone—psoriasis	0.00102	0.00367	CrCrCtD
Fludrocortisone—Desoximetasone—Triamcinolone—psoriasis	0.00101	0.00365	CrCrCtD
Fludrocortisone—Amcinonide—Prednisolone—psoriasis	0.00101	0.00365	CrCrCtD
Fludrocortisone—Fluoxymesterone—Prednisolone—psoriasis	0.00101	0.00365	CrCrCtD
Fludrocortisone—Mometasone—Betamethasone—psoriasis	0.00101	0.00365	CrCrCtD
Fludrocortisone—Loteprednol—Betamethasone—psoriasis	0.00101	0.00365	CrCrCtD
Fludrocortisone—Fluorometholone—Dexamethasone—psoriasis	0.00101	0.00365	CrCrCtD
Fludrocortisone—Fluprednidene Acetate—Betamethasone—psoriasis	0.00101	0.00365	CrCrCtD
Fludrocortisone—Fluprednidene Acetate—Dexamethasone—psoriasis	0.00101	0.00365	CrCrCtD
Fludrocortisone—Loteprednol—Dexamethasone—psoriasis	0.00101	0.00365	CrCrCtD
Fludrocortisone—Mometasone—Dexamethasone—psoriasis	0.00101	0.00365	CrCrCtD
Fludrocortisone—Triamcinolone—Dexamethasone—psoriasis	0.00101	0.00365	CrCrCtD
Fludrocortisone—Triamcinolone—Betamethasone—psoriasis	0.00101	0.00365	CrCrCtD
Fludrocortisone—Fluorometholone—Betamethasone—psoriasis	0.00101	0.00365	CrCrCtD
Fludrocortisone—Diflorasone—Prednisone—psoriasis	0.00101	0.00365	CrCrCtD
Fludrocortisone—Desonide—Prednisone—psoriasis	0.00101	0.00365	CrCrCtD
Fludrocortisone—Clobetasol propionate—Prednisone—psoriasis	0.00101	0.00365	CrCrCtD
Fludrocortisone—Prednisolone—Hydrocortisone—psoriasis	0.000994	0.0036	CrCrCtD
Fludrocortisone—Dexamethasone—Betamethasone—psoriasis	0.000986	0.00357	CrCrCtD
Fludrocortisone—Betamethasone—Dexamethasone—psoriasis	0.000986	0.00357	CrCrCtD
Fludrocortisone—Mometasone—Triamcinolone—psoriasis	0.000985	0.00357	CrCrCtD
Fludrocortisone—Fluorometholone—Triamcinolone—psoriasis	0.000985	0.00357	CrCrCtD
Fludrocortisone—Fluprednidene Acetate—Triamcinolone—psoriasis	0.000985	0.00357	CrCrCtD
Fludrocortisone—Loteprednol—Triamcinolone—psoriasis	0.000985	0.00357	CrCrCtD
Fludrocortisone—Prednisone—Prednisolone—psoriasis	0.000983	0.00356	CrCrCtD
Fludrocortisone—Progesterone—Prednisolone—psoriasis	0.000983	0.00356	CrCrCtD
Fludrocortisone—Diflorasone—Prednisolone—psoriasis	0.000983	0.00356	CrCrCtD
Fludrocortisone—Desonide—Prednisolone—psoriasis	0.000983	0.00356	CrCrCtD
Fludrocortisone—Clobetasol propionate—Prednisolone—psoriasis	0.000983	0.00356	CrCrCtD
Fludrocortisone—Methyltestosterone—Prednisone—psoriasis	0.000982	0.00355	CrCrCtD
Fludrocortisone—Dexamethasone—Triamcinolone—psoriasis	0.000963	0.00349	CrCrCtD
Fludrocortisone—Betamethasone—Triamcinolone—psoriasis	0.000963	0.00349	CrCrCtD
Fludrocortisone—Methyltestosterone—Prednisolone—psoriasis	0.000958	0.00347	CrCrCtD
Fludrocortisone—Desoximetasone—Prednisone—psoriasis	0.000958	0.00347	CrCrCtD
Fludrocortisone—Methylprednisolone—Dexamethasone—psoriasis	0.000943	0.00341	CrCrCtD
Fludrocortisone—Methylprednisolone—Betamethasone—psoriasis	0.000943	0.00341	CrCrCtD
Fludrocortisone—Mometasone—Prednisone—psoriasis	0.000935	0.00339	CrCrCtD
Fludrocortisone—Fluprednidene Acetate—Prednisone—psoriasis	0.000935	0.00339	CrCrCtD
Fludrocortisone—Loteprednol—Prednisone—psoriasis	0.000935	0.00339	CrCrCtD
Fludrocortisone—Fluorometholone—Prednisone—psoriasis	0.000935	0.00339	CrCrCtD
Fludrocortisone—Triamcinolone—Prednisone—psoriasis	0.000935	0.00339	CrCrCtD
Fludrocortisone—Desoximetasone—Prednisolone—psoriasis	0.000935	0.00339	CrCrCtD
Fludrocortisone—Prednisolone—Betamethasone—psoriasis	0.000923	0.00334	CrCrCtD
Fludrocortisone—Prednisolone—Dexamethasone—psoriasis	0.000923	0.00334	CrCrCtD
Fludrocortisone—Methylprednisolone—Triamcinolone—psoriasis	0.000921	0.00333	CrCrCtD
Fludrocortisone—Betamethasone—Prednisone—psoriasis	0.000914	0.00331	CrCrCtD
Fludrocortisone—Dexamethasone—Prednisone—psoriasis	0.000914	0.00331	CrCrCtD
Fludrocortisone—Fluprednidene Acetate—Prednisolone—psoriasis	0.000913	0.00331	CrCrCtD
Fludrocortisone—Loteprednol—Prednisolone—psoriasis	0.000913	0.00331	CrCrCtD
Fludrocortisone—Triamcinolone—Prednisolone—psoriasis	0.000913	0.00331	CrCrCtD
Fludrocortisone—Mometasone—Prednisolone—psoriasis	0.000913	0.00331	CrCrCtD
Fludrocortisone—Fluorometholone—Prednisolone—psoriasis	0.000913	0.00331	CrCrCtD
Fludrocortisone—Prednisolone—Triamcinolone—psoriasis	0.000902	0.00326	CrCrCtD
Fludrocortisone—Dexamethasone—Prednisolone—psoriasis	0.000892	0.00323	CrCrCtD
Fludrocortisone—Betamethasone—Prednisolone—psoriasis	0.000892	0.00323	CrCrCtD
Fludrocortisone—Hydrocortisone—Betamethasone—psoriasis	0.000886	0.00321	CrCrCtD
Fludrocortisone—Hydrocortisone—Dexamethasone—psoriasis	0.000886	0.00321	CrCrCtD
Fludrocortisone—Methylprednisolone—Prednisone—psoriasis	0.000874	0.00316	CrCrCtD
Fludrocortisone—Hydrocortisone—Triamcinolone—psoriasis	0.000865	0.00313	CrCrCtD
Fludrocortisone—Prednisolone—Prednisone—psoriasis	0.000856	0.0031	CrCrCtD
Fludrocortisone—Methylprednisolone—Prednisolone—psoriasis	0.000853	0.00309	CrCrCtD
Fludrocortisone—Testosterone—Prednisolone—psoriasis	0.000853	0.00309	CrCrCtD
Fludrocortisone—Hydrocortisone—Prednisone—psoriasis	0.000821	0.00297	CrCrCtD
Fludrocortisone—Hydrocortisone—Prednisolone—psoriasis	0.000802	0.0029	CrCrCtD
Fludrocortisone—NR3C2—ACE Inhibitor Pathway—ACE—psoriasis	0.000696	0.0872	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—ZMIZ1—psoriasis	0.000234	0.0294	CbGpPWpGaD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000224	0.0281	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—ZMIZ1—psoriasis	0.000173	0.0217	CbGpPWpGaD
Fludrocortisone—AR—Regulation of Androgen receptor activity—REL—psoriasis	0.000171	0.0215	CbGpPWpGaD
Fludrocortisone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CARM1—psoriasis	0.000171	0.0214	CbGpPWpGaD
Fludrocortisone—AR—Regulation of Androgen receptor activity—CARM1—psoriasis	0.000169	0.0212	CbGpPWpGaD
Fludrocortisone—NR3C2—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000156	0.0196	CbGpPWpGaD
Fludrocortisone—AR—Coregulation of Androgen receptor activity—CARM1—psoriasis	0.000151	0.0189	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—RUNX3—psoriasis	0.000141	0.0177	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptors—VDR—psoriasis	0.000132	0.0165	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—REL—psoriasis	0.00013	0.0163	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—CARM1—psoriasis	0.000128	0.0161	CbGpPWpGaD
Fludrocortisone—NR3C1—Circadian Clock—CARM1—psoriasis	0.000124	0.0156	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—LEP—psoriasis	0.000124	0.0155	CbGpPWpGaD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—ZMIZ1—psoriasis	0.000113	0.0142	CbGpPWpGaD
Fludrocortisone—AR—Androgen receptor signaling pathway—CARM1—psoriasis	0.000112	0.014	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—psoriasis	0.000108	0.0135	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—psoriasis	0.000107	0.0135	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000104	0.013	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptors—VDR—psoriasis	9.98e-05	0.0125	CbGpPWpGaD
Fludrocortisone—NR3C2—Gene Expression—TARS—psoriasis	9.92e-05	0.0124	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptors—PPARG—psoriasis	9.18e-05	0.0115	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL13—psoriasis	8.39e-05	0.0105	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—RUNX3—psoriasis	8.38e-05	0.0105	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—VDR—psoriasis	7.89e-05	0.0099	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	7.88e-05	0.00988	CbGpPWpGaD
Fludrocortisone—AR—Nuclear Receptor transcription pathway—PPARG—psoriasis	7.25e-05	0.00909	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	7.18e-05	0.00901	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	6.99e-05	0.00876	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptors—PPARG—psoriasis	6.96e-05	0.00873	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL13—psoriasis	6.61e-05	0.00829	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—CARM1—psoriasis	6.48e-05	0.00813	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—RUNX3—psoriasis	6.35e-05	0.00797	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—CD4—psoriasis	6.13e-05	0.00769	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL10—psoriasis	5.96e-05	0.00747	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL4—psoriasis	5.8e-05	0.00727	CbGpPWpGaD
Fludrocortisone—AR—FOXA1 transcription factor network—JUN—psoriasis	5.79e-05	0.00726	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—TNF—psoriasis	5.72e-05	0.00718	CbGpPWpGaD
Fludrocortisone—NR3C1—Nuclear Receptor transcription pathway—PPARG—psoriasis	5.5e-05	0.0069	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—psoriasis	5.45e-05	0.00684	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—psoriasis	5.3e-05	0.00665	CbGpPWpGaD
Fludrocortisone—NR3C1—AP-1 transcription factor network—HLA-A—psoriasis	5.25e-05	0.00659	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL4—psoriasis	5.11e-05	0.00641	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL13—psoriasis	5.02e-05	0.00629	CbGpPWpGaD
Fludrocortisone—AR—Regulation of Androgen receptor activity—JUN—psoriasis	4.99e-05	0.00626	CbGpPWpGaD
Fludrocortisone—AR—Notch-mediated HES/HEY network—STAT3—psoriasis	4.75e-05	0.00596	CbGpPWpGaD
Fludrocortisone—NR3C1—Transcription factor regulation in adipogenesis—IL6—psoriasis	4.62e-05	0.00579	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—TARS—psoriasis	4.6e-05	0.00577	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL10—psoriasis	4.14e-05	0.00519	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—psoriasis	4.06e-05	0.00509	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—SOCS1—psoriasis	4.05e-05	0.00508	CbGpPWpGaD
Fludrocortisone—NR3C2—Generic Transcription Pathway—VDR—psoriasis	3.87e-05	0.00486	CbGpPWpGaD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—psoriasis	3.86e-05	0.00484	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Acitretin—psoriasis	3.82e-05	0.000491	CcSEcCtD
Fludrocortisone—Erythema—Hydroxyurea—psoriasis	3.8e-05	0.000489	CcSEcCtD
Fludrocortisone—NR3C1—Regulation of Androgen receptor activity—JUN—psoriasis	3.78e-05	0.00475	CbGpPWpGaD
Fludrocortisone—Muscular weakness—Cyclosporine—psoriasis	3.77e-05	0.000485	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Dexamethasone—psoriasis	3.75e-05	0.000482	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Betamethasone—psoriasis	3.75e-05	0.000482	CcSEcCtD
Fludrocortisone—Affect lability—Hydrocortisone—psoriasis	3.74e-05	0.000481	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Betamethasone—psoriasis	3.73e-05	0.00048	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Dexamethasone—psoriasis	3.73e-05	0.00048	CcSEcCtD
Fludrocortisone—Abdominal distension—Cyclosporine—psoriasis	3.72e-05	0.000479	CcSEcCtD
Fludrocortisone—Purpura—Triamcinolone—psoriasis	3.71e-05	0.000478	CcSEcCtD
Fludrocortisone—Fluid retention—Prednisone—psoriasis	3.7e-05	0.000476	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Triamcinolone—psoriasis	3.7e-05	0.000476	CcSEcCtD
Fludrocortisone—Mood swings—Prednisolone—psoriasis	3.69e-05	0.000474	CcSEcCtD
Fludrocortisone—Muscular weakness—Mycophenolate mofetil—psoriasis	3.68e-05	0.000473	CcSEcCtD
Fludrocortisone—Haemoglobin—Mycophenolic acid—psoriasis	3.68e-05	0.000473	CcSEcCtD
Fludrocortisone—Hypersensitivity—Methoxsalen—psoriasis	3.67e-05	0.000472	CcSEcCtD
Fludrocortisone—Haemorrhage—Mycophenolic acid—psoriasis	3.66e-05	0.00047	CcSEcCtD
Fludrocortisone—Abdominal distension—Mycophenolate mofetil—psoriasis	3.63e-05	0.000467	CcSEcCtD
Fludrocortisone—Pancreatitis—Cyclosporine—psoriasis	3.62e-05	0.000466	CcSEcCtD
Fludrocortisone—Sweating increased—Cyclosporine—psoriasis	3.6e-05	0.000463	CcSEcCtD
Fludrocortisone—Mood swings—Hydrocortisone—psoriasis	3.6e-05	0.000463	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Acitretin—psoriasis	3.6e-05	0.000463	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Fluocinolone Acetonide—psoriasis	3.59e-05	0.000462	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—psoriasis	3.59e-05	0.0045	CbGpPWpGaD
Fludrocortisone—Cardiac failure congestive—Dexamethasone—psoriasis	3.58e-05	0.00046	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Betamethasone—psoriasis	3.58e-05	0.00046	CcSEcCtD
Fludrocortisone—Insomnia—Acitretin—psoriasis	3.57e-05	0.00046	CcSEcCtD
Fludrocortisone—Oesophagitis—Prednisone—psoriasis	3.56e-05	0.000458	CcSEcCtD
Fludrocortisone—AR—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	3.55e-05	0.00446	CbGpPWpGaD
Fludrocortisone—Pancreatitis—Mycophenolate mofetil—psoriasis	3.54e-05	0.000455	CcSEcCtD
Fludrocortisone—Injury—Dexamethasone—psoriasis	3.53e-05	0.000454	CcSEcCtD
Fludrocortisone—Injury—Betamethasone—psoriasis	3.53e-05	0.000454	CcSEcCtD
Fludrocortisone—Urticaria—Calcitriol—psoriasis	3.53e-05	0.000454	CcSEcCtD
Fludrocortisone—Affect lability—Triamcinolone—psoriasis	3.52e-05	0.000453	CcSEcCtD
Fludrocortisone—Ecchymosis—Prednisone—psoriasis	3.52e-05	0.000453	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IFNG—psoriasis	3.5e-05	0.00439	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—TARS—psoriasis	3.49e-05	0.00438	CbGpPWpGaD
Fludrocortisone—Muscular weakness—Prednisolone—psoriasis	3.43e-05	0.000441	CcSEcCtD
Fludrocortisone—Mood swings—Triamcinolone—psoriasis	3.39e-05	0.000436	CcSEcCtD
Fludrocortisone—Abdominal distension—Prednisolone—psoriasis	3.39e-05	0.000435	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Betamethasone—psoriasis	3.36e-05	0.000431	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Dexamethasone—psoriasis	3.36e-05	0.000431	CcSEcCtD
Fludrocortisone—Muscular weakness—Hydrocortisone—psoriasis	3.35e-05	0.000431	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Cyclosporine—psoriasis	3.33e-05	0.000429	CcSEcCtD
Fludrocortisone—Abdominal distension—Hydrocortisone—psoriasis	3.31e-05	0.000425	CcSEcCtD
Fludrocortisone—Pancreatitis—Prednisolone—psoriasis	3.3e-05	0.000424	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—JUN—psoriasis	3.29e-05	0.00413	CbGpPWpGaD
Fludrocortisone—Convulsion—Hydroxyurea—psoriasis	3.29e-05	0.000424	CcSEcCtD
Fludrocortisone—Sweating increased—Prednisolone—psoriasis	3.28e-05	0.000421	CcSEcCtD
Fludrocortisone—Hypersensitivity—Calcitriol—psoriasis	3.27e-05	0.000421	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Prednisone—psoriasis	3.27e-05	0.00042	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—CXCL8—psoriasis	3.26e-05	0.00409	CbGpPWpGaD
Fludrocortisone—Hyperglycaemia—Mycophenolate mofetil—psoriasis	3.25e-05	0.000418	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Prednisone—psoriasis	3.25e-05	0.000418	CcSEcCtD
Fludrocortisone—Pancreatitis—Hydrocortisone—psoriasis	3.22e-05	0.000414	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3.21e-05	0.00403	CbGpPWpGaD
Fludrocortisone—Sweating increased—Hydrocortisone—psoriasis	3.2e-05	0.000412	CcSEcCtD
Fludrocortisone—Affect lability—Betamethasone—psoriasis	3.2e-05	0.000411	CcSEcCtD
Fludrocortisone—Affect lability—Dexamethasone—psoriasis	3.2e-05	0.000411	CcSEcCtD
Fludrocortisone—Asthenia—Calcitriol—psoriasis	3.19e-05	0.00041	CcSEcCtD
Fludrocortisone—Vascular purpura—Prednisone—psoriasis	3.16e-05	0.000407	CcSEcCtD
Fludrocortisone—Muscular weakness—Triamcinolone—psoriasis	3.16e-05	0.000406	CcSEcCtD
Fludrocortisone—Urticaria—Acitretin—psoriasis	3.14e-05	0.000404	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL10—psoriasis	3.14e-05	0.00394	CbGpPWpGaD
Fludrocortisone—Headache—Methoxsalen—psoriasis	3.12e-05	0.000401	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—CARM1—psoriasis	3.12e-05	0.00392	CbGpPWpGaD
Fludrocortisone—Cardiac failure congestive—Prednisone—psoriasis	3.12e-05	0.000401	CcSEcCtD
Fludrocortisone—Abdominal distension—Triamcinolone—psoriasis	3.11e-05	0.0004	CcSEcCtD
Fludrocortisone—Oedema—Hydroxyurea—psoriasis	3.1e-05	0.000399	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—psoriasis	3.09e-05	0.00387	CbGpPWpGaD
Fludrocortisone—Infection—Hydroxyurea—psoriasis	3.08e-05	0.000396	CcSEcCtD
Fludrocortisone—Injury—Prednisone—psoriasis	3.08e-05	0.000396	CcSEcCtD
Fludrocortisone—Mood swings—Dexamethasone—psoriasis	3.08e-05	0.000396	CcSEcCtD
Fludrocortisone—Mood swings—Betamethasone—psoriasis	3.08e-05	0.000396	CcSEcCtD
Fludrocortisone—Pancreatitis—Triamcinolone—psoriasis	3.03e-05	0.00039	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—JUN—psoriasis	3.03e-05	0.0038	CbGpPWpGaD
Fludrocortisone—Sweating increased—Triamcinolone—psoriasis	3.01e-05	0.000387	CcSEcCtD
Fludrocortisone—AR—Generic Transcription Pathway—CARM1—psoriasis	3.01e-05	0.00377	CbGpPWpGaD
Fludrocortisone—NR3C1—Adipogenesis—LEP—psoriasis	2.99e-05	0.00375	CbGpPWpGaD
Fludrocortisone—Haemoglobin—Cyclosporine—psoriasis	2.97e-05	0.000382	CcSEcCtD
Fludrocortisone—Haemorrhage—Cyclosporine—psoriasis	2.96e-05	0.00038	CcSEcCtD
Fludrocortisone—Neoplasm—Methotrexate—psoriasis	2.94e-05	0.000379	CcSEcCtD
Fludrocortisone—Ecchymosis—Methotrexate—psoriasis	2.94e-05	0.000379	CcSEcCtD
Fludrocortisone—Purpura—Prednisone—psoriasis	2.93e-05	0.000377	CcSEcCtD
Fludrocortisone—Hypersensitivity—Acitretin—psoriasis	2.91e-05	0.000374	CcSEcCtD
Fludrocortisone—Hypersensitivity—Fluocinolone Acetonide—psoriasis	2.9e-05	0.000373	CcSEcCtD
Fludrocortisone—Haemoglobin—Mycophenolate mofetil—psoriasis	2.9e-05	0.000373	CcSEcCtD
Fludrocortisone—Haemorrhage—Mycophenolate mofetil—psoriasis	2.89e-05	0.000371	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—psoriasis	2.87e-05	0.0036	CbGpPWpGaD
Fludrocortisone—Muscular weakness—Betamethasone—psoriasis	2.86e-05	0.000368	CcSEcCtD
Fludrocortisone—Muscular weakness—Dexamethasone—psoriasis	2.86e-05	0.000368	CcSEcCtD
Fludrocortisone—Vertigo—Mycophenolic acid—psoriasis	2.86e-05	0.000368	CcSEcCtD
Fludrocortisone—AR—Androgen receptor signaling pathway—STAT3—psoriasis	2.85e-05	0.00357	CbGpPWpGaD
Fludrocortisone—Asthenia—Acitretin—psoriasis	2.84e-05	0.000365	CcSEcCtD
Fludrocortisone—Affect lability—Prednisone—psoriasis	2.78e-05	0.000358	CcSEcCtD
Fludrocortisone—Headache—Calcitriol—psoriasis	2.78e-05	0.000358	CcSEcCtD
Fludrocortisone—Convulsion—Mycophenolic acid—psoriasis	2.76e-05	0.000355	CcSEcCtD
Fludrocortisone—Hypertension—Mycophenolic acid—psoriasis	2.75e-05	0.000353	CcSEcCtD
Fludrocortisone—Sweating increased—Betamethasone—psoriasis	2.73e-05	0.000352	CcSEcCtD
Fludrocortisone—Sweating increased—Dexamethasone—psoriasis	2.73e-05	0.000352	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Methotrexate—psoriasis	2.73e-05	0.000351	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Methotrexate—psoriasis	2.72e-05	0.000349	CcSEcCtD
Fludrocortisone—Myalgia—Mycophenolic acid—psoriasis	2.71e-05	0.000349	CcSEcCtD
Fludrocortisone—Haemoglobin—Prednisolone—psoriasis	2.71e-05	0.000348	CcSEcCtD
Fludrocortisone—NR3C2—Generic Transcription Pathway—PPARG—psoriasis	2.7e-05	0.00339	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.7e-05	0.00338	CbGpPWpGaD
Fludrocortisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—psoriasis	2.69e-05	0.00338	CbGpPWpGaD
Fludrocortisone—Haemorrhage—Prednisolone—psoriasis	2.69e-05	0.000346	CcSEcCtD
Fludrocortisone—Mood swings—Prednisone—psoriasis	2.68e-05	0.000345	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—JUN—psoriasis	2.67e-05	0.00335	CbGpPWpGaD
Fludrocortisone—Haemoglobin—Hydrocortisone—psoriasis	2.64e-05	0.00034	CcSEcCtD
Fludrocortisone—Haemorrhage—Hydrocortisone—psoriasis	2.63e-05	0.000338	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—PPARG—psoriasis	2.6e-05	0.00326	CbGpPWpGaD
Fludrocortisone—Oedema—Mycophenolic acid—psoriasis	2.6e-05	0.000334	CcSEcCtD
Fludrocortisone—Infection—Mycophenolic acid—psoriasis	2.58e-05	0.000332	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—NFKB1—psoriasis	2.57e-05	0.00322	CbGpPWpGaD
Fludrocortisone—Hyperglycaemia—Dexamethasone—psoriasis	2.53e-05	0.000326	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Betamethasone—psoriasis	2.53e-05	0.000326	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Mycophenolic acid—psoriasis	2.51e-05	0.000323	CcSEcCtD
Fludrocortisone—Muscular weakness—Prednisone—psoriasis	2.49e-05	0.000321	CcSEcCtD
Fludrocortisone—Haemoglobin—Triamcinolone—psoriasis	2.49e-05	0.00032	CcSEcCtD
Fludrocortisone—Haemorrhage—Triamcinolone—psoriasis	2.48e-05	0.000318	CcSEcCtD
Fludrocortisone—Headache—Acitretin—psoriasis	2.48e-05	0.000318	CcSEcCtD
Fludrocortisone—Headache—Fluocinolone Acetonide—psoriasis	2.47e-05	0.000317	CcSEcCtD
Fludrocortisone—Abdominal distension—Prednisone—psoriasis	2.46e-05	0.000316	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Methotrexate—psoriasis	2.44e-05	0.000314	CcSEcCtD
Fludrocortisone—Pancreatitis—Prednisone—psoriasis	2.4e-05	0.000308	CcSEcCtD
Fludrocortisone—Sweating increased—Prednisone—psoriasis	2.38e-05	0.000306	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Mycophenolic acid—psoriasis	2.37e-05	0.000304	CcSEcCtD
Fludrocortisone—Insomnia—Mycophenolic acid—psoriasis	2.35e-05	0.000302	CcSEcCtD
Fludrocortisone—Erythema—Prednisolone—psoriasis	2.34e-05	0.000301	CcSEcCtD
Fludrocortisone—Vertigo—Cyclosporine—psoriasis	2.31e-05	0.000298	CcSEcCtD
Fludrocortisone—Erythema—Hydrocortisone—psoriasis	2.29e-05	0.000294	CcSEcCtD
Fludrocortisone—Hypersensitivity—Hydroxyurea—psoriasis	2.29e-05	0.000294	CcSEcCtD
Fludrocortisone—NR3C1—Generic Transcription Pathway—CARM1—psoriasis	2.28e-05	0.00286	CbGpPWpGaD
Fludrocortisone—AR—SIDS Susceptibility Pathways—CXCL8—psoriasis	2.26e-05	0.00284	CbGpPWpGaD
Fludrocortisone—Haemoglobin—Dexamethasone—psoriasis	2.26e-05	0.00029	CcSEcCtD
Fludrocortisone—Haemoglobin—Betamethasone—psoriasis	2.26e-05	0.00029	CcSEcCtD
Fludrocortisone—Vertigo—Mycophenolate mofetil—psoriasis	2.26e-05	0.00029	CcSEcCtD
Fludrocortisone—Haemorrhage—Dexamethasone—psoriasis	2.25e-05	0.000289	CcSEcCtD
Fludrocortisone—Haemorrhage—Betamethasone—psoriasis	2.25e-05	0.000289	CcSEcCtD
Fludrocortisone—Mood swings—Methotrexate—psoriasis	2.24e-05	0.000288	CcSEcCtD
Fludrocortisone—Convulsion—Cyclosporine—psoriasis	2.23e-05	0.000287	CcSEcCtD
Fludrocortisone—Asthenia—Hydroxyurea—psoriasis	2.23e-05	0.000286	CcSEcCtD
Fludrocortisone—Hypertension—Cyclosporine—psoriasis	2.22e-05	0.000286	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Prednisone—psoriasis	2.2e-05	0.000284	CcSEcCtD
Fludrocortisone—Myalgia—Cyclosporine—psoriasis	2.19e-05	0.000282	CcSEcCtD
Fludrocortisone—Convulsion—Mycophenolate mofetil—psoriasis	2.18e-05	0.00028	CcSEcCtD
Fludrocortisone—Hypertension—Mycophenolate mofetil—psoriasis	2.17e-05	0.000279	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—JUN—psoriasis	2.16e-05	0.00271	CbGpPWpGaD
Fludrocortisone—Erythema—Triamcinolone—psoriasis	2.16e-05	0.000277	CcSEcCtD
Fludrocortisone—Myalgia—Mycophenolate mofetil—psoriasis	2.14e-05	0.000275	CcSEcCtD
Fludrocortisone—Vertigo—Prednisolone—psoriasis	2.11e-05	0.000271	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—JUN—psoriasis	2.1e-05	0.00264	CbGpPWpGaD
Fludrocortisone—Oedema—Cyclosporine—psoriasis	2.1e-05	0.00027	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Cyclosporine—psoriasis	2.1e-05	0.00027	CcSEcCtD
Fludrocortisone—Infection—Cyclosporine—psoriasis	2.09e-05	0.000269	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—NFKB1—psoriasis	2.08e-05	0.00261	CbGpPWpGaD
Fludrocortisone—Vertigo—Hydrocortisone—psoriasis	2.06e-05	0.000264	CcSEcCtD
Fludrocortisone—Oedema—Mycophenolate mofetil—psoriasis	2.05e-05	0.000264	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Mycophenolate mofetil—psoriasis	2.05e-05	0.000264	CcSEcCtD
Fludrocortisone—Infection—Mycophenolate mofetil—psoriasis	2.04e-05	0.000262	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Cyclosporine—psoriasis	2.03e-05	0.000261	CcSEcCtD
Fludrocortisone—Convulsion—Prednisolone—psoriasis	2.03e-05	0.000261	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—NFKB1—psoriasis	2.02e-05	0.00254	CbGpPWpGaD
Fludrocortisone—Hypertension—Prednisolone—psoriasis	2.02e-05	0.00026	CcSEcCtD
Fludrocortisone—Pancreatitis—Methotrexate—psoriasis	2e-05	0.000258	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—TP53—psoriasis	2e-05	0.00251	CbGpPWpGaD
Fludrocortisone—Convulsion—Hydrocortisone—psoriasis	1.98e-05	0.000255	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Mycophenolate mofetil—psoriasis	1.98e-05	0.000255	CcSEcCtD
Fludrocortisone—Hypertension—Hydrocortisone—psoriasis	1.98e-05	0.000254	CcSEcCtD
Fludrocortisone—Haemoglobin—Prednisone—psoriasis	1.97e-05	0.000253	CcSEcCtD
Fludrocortisone—Haemorrhage—Prednisone—psoriasis	1.96e-05	0.000252	CcSEcCtD
Fludrocortisone—Erythema—Betamethasone—psoriasis	1.96e-05	0.000251	CcSEcCtD
Fludrocortisone—Erythema—Dexamethasone—psoriasis	1.96e-05	0.000251	CcSEcCtD
Fludrocortisone—Myalgia—Hydrocortisone—psoriasis	1.95e-05	0.000251	CcSEcCtD
Fludrocortisone—Headache—Hydroxyurea—psoriasis	1.94e-05	0.00025	CcSEcCtD
Fludrocortisone—Vertigo—Triamcinolone—psoriasis	1.94e-05	0.000249	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Cyclosporine—psoriasis	1.92e-05	0.000246	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Prednisolone—psoriasis	1.91e-05	0.000246	CcSEcCtD
Fludrocortisone—Oedema—Prednisolone—psoriasis	1.91e-05	0.000246	CcSEcCtD
Fludrocortisone—Insomnia—Cyclosporine—psoriasis	1.9e-05	0.000244	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—VEGFA—psoriasis	1.89e-05	0.00236	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	1.87e-05	0.00024	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Hydrocortisone—psoriasis	1.87e-05	0.00024	CcSEcCtD
Fludrocortisone—Oedema—Hydrocortisone—psoriasis	1.87e-05	0.00024	CcSEcCtD
Fludrocortisone—Convulsion—Triamcinolone—psoriasis	1.87e-05	0.00024	CcSEcCtD
Fludrocortisone—Asthenia—Mycophenolic acid—psoriasis	1.86e-05	0.00024	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—VDR—psoriasis	1.86e-05	0.00234	CbGpPWpGaD
Fludrocortisone—Hypertension—Triamcinolone—psoriasis	1.86e-05	0.000239	CcSEcCtD
Fludrocortisone—Infection—Hydrocortisone—psoriasis	1.86e-05	0.000239	CcSEcCtD
Fludrocortisone—Insomnia—Mycophenolate mofetil—psoriasis	1.85e-05	0.000238	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Prednisolone—psoriasis	1.85e-05	0.000238	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—VEGFA—psoriasis	1.84e-05	0.0023	CbGpPWpGaD
Fludrocortisone—Myalgia—Triamcinolone—psoriasis	1.83e-05	0.000236	CcSEcCtD
Fludrocortisone—NR3C1—AP-1 transcription factor network—IL6—psoriasis	1.83e-05	0.0023	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Hydrocortisone—psoriasis	1.81e-05	0.000232	CcSEcCtD
Fludrocortisone—AR—Generic Transcription Pathway—VDR—psoriasis	1.8e-05	0.00225	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.79e-05	0.00224	CbGpPWpGaD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—psoriasis	1.76e-05	0.00221	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Triamcinolone—psoriasis	1.76e-05	0.000226	CcSEcCtD
Fludrocortisone—Oedema—Triamcinolone—psoriasis	1.76e-05	0.000226	CcSEcCtD
Fludrocortisone—Vertigo—Dexamethasone—psoriasis	1.76e-05	0.000226	CcSEcCtD
Fludrocortisone—Vertigo—Betamethasone—psoriasis	1.76e-05	0.000226	CcSEcCtD
Fludrocortisone—Infection—Triamcinolone—psoriasis	1.75e-05	0.000225	CcSEcCtD
Fludrocortisone—Insomnia—Prednisolone—psoriasis	1.73e-05	0.000222	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.72e-05	0.00216	CbGpPWpGaD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—CXCL8—psoriasis	1.72e-05	0.00215	CbGpPWpGaD
Fludrocortisone—Erythema—Prednisone—psoriasis	1.7e-05	0.000219	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Hydrocortisone—psoriasis	1.7e-05	0.000219	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Triamcinolone—psoriasis	1.7e-05	0.000219	CcSEcCtD
Fludrocortisone—Convulsion—Betamethasone—psoriasis	1.69e-05	0.000218	CcSEcCtD
Fludrocortisone—Convulsion—Dexamethasone—psoriasis	1.69e-05	0.000218	CcSEcCtD
Fludrocortisone—Insomnia—Hydrocortisone—psoriasis	1.69e-05	0.000217	CcSEcCtD
Fludrocortisone—Hypertension—Dexamethasone—psoriasis	1.69e-05	0.000217	CcSEcCtD
Fludrocortisone—Hypertension—Betamethasone—psoriasis	1.69e-05	0.000217	CcSEcCtD
Fludrocortisone—Urticaria—Cyclosporine—psoriasis	1.67e-05	0.000215	CcSEcCtD
Fludrocortisone—Myalgia—Betamethasone—psoriasis	1.66e-05	0.000214	CcSEcCtD
Fludrocortisone—Myalgia—Dexamethasone—psoriasis	1.66e-05	0.000214	CcSEcCtD
Fludrocortisone—Haemoglobin—Methotrexate—psoriasis	1.64e-05	0.000211	CcSEcCtD
Fludrocortisone—Haemorrhage—Methotrexate—psoriasis	1.64e-05	0.00021	CcSEcCtD
Fludrocortisone—Urticaria—Mycophenolate mofetil—psoriasis	1.63e-05	0.000209	CcSEcCtD
Fludrocortisone—Headache—Mycophenolic acid—psoriasis	1.63e-05	0.000209	CcSEcCtD
Fludrocortisone—NR3C1—Glucocorticoid receptor regulatory network—IL6—psoriasis	1.61e-05	0.00202	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Triamcinolone—psoriasis	1.6e-05	0.000206	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—STAT3—psoriasis	1.6e-05	0.002	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Betamethasone—psoriasis	1.6e-05	0.000205	CcSEcCtD
Fludrocortisone—Oedema—Betamethasone—psoriasis	1.6e-05	0.000205	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Dexamethasone—psoriasis	1.6e-05	0.000205	CcSEcCtD
Fludrocortisone—Oedema—Dexamethasone—psoriasis	1.6e-05	0.000205	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—JUN—psoriasis	1.6e-05	0.002	CbGpPWpGaD
Fludrocortisone—Insomnia—Triamcinolone—psoriasis	1.59e-05	0.000205	CcSEcCtD
Fludrocortisone—Infection—Dexamethasone—psoriasis	1.59e-05	0.000204	CcSEcCtD
Fludrocortisone—Infection—Betamethasone—psoriasis	1.59e-05	0.000204	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—TNF—psoriasis	1.57e-05	0.00197	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.56e-05	0.00196	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Cyclosporine—psoriasis	1.55e-05	0.000199	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Betamethasone—psoriasis	1.54e-05	0.000198	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Dexamethasone—psoriasis	1.54e-05	0.000198	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—NFKB1—psoriasis	1.54e-05	0.00193	CbGpPWpGaD
Fludrocortisone—Vertigo—Prednisone—psoriasis	1.53e-05	0.000197	CcSEcCtD
Fludrocortisone—Urticaria—Prednisolone—psoriasis	1.52e-05	0.000195	CcSEcCtD
Fludrocortisone—Hypersensitivity—Mycophenolate mofetil—psoriasis	1.51e-05	0.000194	CcSEcCtD
Fludrocortisone—Asthenia—Cyclosporine—psoriasis	1.51e-05	0.000194	CcSEcCtD
Fludrocortisone—Urticaria—Hydrocortisone—psoriasis	1.48e-05	0.000191	CcSEcCtD
Fludrocortisone—Convulsion—Prednisone—psoriasis	1.48e-05	0.00019	CcSEcCtD
Fludrocortisone—Asthenia—Mycophenolate mofetil—psoriasis	1.47e-05	0.000189	CcSEcCtD
Fludrocortisone—Hypertension—Prednisone—psoriasis	1.47e-05	0.000189	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Dexamethasone—psoriasis	1.45e-05	0.000187	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Betamethasone—psoriasis	1.45e-05	0.000187	CcSEcCtD
Fludrocortisone—Myalgia—Prednisone—psoriasis	1.45e-05	0.000186	CcSEcCtD
Fludrocortisone—AR—Gene Expression—CARM1—psoriasis	1.45e-05	0.00182	CbGpPWpGaD
Fludrocortisone—Insomnia—Betamethasone—psoriasis	1.44e-05	0.000186	CcSEcCtD
Fludrocortisone—Insomnia—Dexamethasone—psoriasis	1.44e-05	0.000186	CcSEcCtD
Fludrocortisone—AR—Integrated Breast Cancer Pathway—TP53—psoriasis	1.42e-05	0.00179	CbGpPWpGaD
Fludrocortisone—Erythema—Methotrexate—psoriasis	1.42e-05	0.000183	CcSEcCtD
Fludrocortisone—Hypersensitivity—Prednisolone—psoriasis	1.41e-05	0.000181	CcSEcCtD
Fludrocortisone—Urticaria—Triamcinolone—psoriasis	1.4e-05	0.00018	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—psoriasis	1.39e-05	0.00175	CbGpPWpGaD
Fludrocortisone—Anaphylactic shock—Prednisone—psoriasis	1.39e-05	0.000179	CcSEcCtD
Fludrocortisone—Oedema—Prednisone—psoriasis	1.39e-05	0.000179	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—TNF—psoriasis	1.38e-05	0.00173	CbGpPWpGaD
Fludrocortisone—Infection—Prednisone—psoriasis	1.38e-05	0.000178	CcSEcCtD
Fludrocortisone—Hypersensitivity—Hydrocortisone—psoriasis	1.38e-05	0.000177	CcSEcCtD
Fludrocortisone—NR3C1—Generic Transcription Pathway—VDR—psoriasis	1.36e-05	0.00171	CbGpPWpGaD
Fludrocortisone—Hyperhidrosis—Prednisone—psoriasis	1.34e-05	0.000173	CcSEcCtD
Fludrocortisone—Asthenia—Hydrocortisone—psoriasis	1.34e-05	0.000172	CcSEcCtD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.34e-05	0.00168	CbGpPWpGaD
Fludrocortisone—Headache—Cyclosporine—psoriasis	1.32e-05	0.000169	CcSEcCtD
Fludrocortisone—NR3C2—Gene Expression—PPARG—psoriasis	1.3e-05	0.00163	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Triamcinolone—psoriasis	1.3e-05	0.000167	CcSEcCtD
Fludrocortisone—Headache—Mycophenolate mofetil—psoriasis	1.28e-05	0.000165	CcSEcCtD
Fludrocortisone—Vertigo—Methotrexate—psoriasis	1.28e-05	0.000164	CcSEcCtD
Fludrocortisone—AR—SIDS Susceptibility Pathways—IL6—psoriasis	1.27e-05	0.00159	CbGpPWpGaD
Fludrocortisone—Urticaria—Dexamethasone—psoriasis	1.27e-05	0.000163	CcSEcCtD
Fludrocortisone—Urticaria—Betamethasone—psoriasis	1.27e-05	0.000163	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Prednisone—psoriasis	1.27e-05	0.000163	CcSEcCtD
Fludrocortisone—Asthenia—Triamcinolone—psoriasis	1.26e-05	0.000162	CcSEcCtD
Fludrocortisone—Insomnia—Prednisone—psoriasis	1.26e-05	0.000162	CcSEcCtD
Fludrocortisone—AR—Generic Transcription Pathway—PPARG—psoriasis	1.25e-05	0.00157	CbGpPWpGaD
Fludrocortisone—Convulsion—Methotrexate—psoriasis	1.23e-05	0.000159	CcSEcCtD
Fludrocortisone—Myalgia—Methotrexate—psoriasis	1.21e-05	0.000156	CcSEcCtD
Fludrocortisone—Headache—Prednisolone—psoriasis	1.2e-05	0.000154	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—TNF—psoriasis	1.19e-05	0.0015	CbGpPWpGaD
Fludrocortisone—AR—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.18e-05	0.00148	CbGpPWpGaD
Fludrocortisone—Headache—Hydrocortisone—psoriasis	1.17e-05	0.00015	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Methotrexate—psoriasis	1.16e-05	0.000149	CcSEcCtD
Fludrocortisone—Infection—Methotrexate—psoriasis	1.15e-05	0.000148	CcSEcCtD
Fludrocortisone—Asthenia—Betamethasone—psoriasis	1.15e-05	0.000147	CcSEcCtD
Fludrocortisone—Asthenia—Dexamethasone—psoriasis	1.15e-05	0.000147	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Methotrexate—psoriasis	1.12e-05	0.000144	CcSEcCtD
Fludrocortisone—NR3C1—Adipogenesis—IL6—psoriasis	1.12e-05	0.0014	CbGpPWpGaD
Fludrocortisone—Urticaria—Prednisone—psoriasis	1.1e-05	0.000142	CcSEcCtD
Fludrocortisone—Headache—Triamcinolone—psoriasis	1.1e-05	0.000142	CcSEcCtD
Fludrocortisone—NR3C1—Gene Expression—CARM1—psoriasis	1.1e-05	0.00138	CbGpPWpGaD
Fludrocortisone—Musculoskeletal discomfort—Methotrexate—psoriasis	1.06e-05	0.000136	CcSEcCtD
Fludrocortisone—Insomnia—Methotrexate—psoriasis	1.05e-05	0.000135	CcSEcCtD
Fludrocortisone—Hypersensitivity—Prednisone—psoriasis	1.02e-05	0.000132	CcSEcCtD
Fludrocortisone—Headache—Dexamethasone—psoriasis	1e-05	0.000129	CcSEcCtD
Fludrocortisone—Headache—Betamethasone—psoriasis	1e-05	0.000129	CcSEcCtD
Fludrocortisone—Asthenia—Prednisone—psoriasis	9.97e-06	0.000128	CcSEcCtD
Fludrocortisone—NR3C1—SIDS Susceptibility Pathways—IL6—psoriasis	9.64e-06	0.00121	CbGpPWpGaD
Fludrocortisone—NR3C1—Generic Transcription Pathway—PPARG—psoriasis	9.5e-06	0.00119	CbGpPWpGaD
Fludrocortisone—Urticaria—Methotrexate—psoriasis	9.23e-06	0.000119	CcSEcCtD
Fludrocortisone—Headache—Prednisone—psoriasis	8.71e-06	0.000112	CcSEcCtD
Fludrocortisone—AR—Gene Expression—VDR—psoriasis	8.65e-06	0.00108	CbGpPWpGaD
Fludrocortisone—Hypersensitivity—Methotrexate—psoriasis	8.56e-06	0.00011	CcSEcCtD
Fludrocortisone—Asthenia—Methotrexate—psoriasis	8.33e-06	0.000107	CcSEcCtD
Fludrocortisone—Headache—Methotrexate—psoriasis	7.28e-06	9.36e-05	CcSEcCtD
Fludrocortisone—NR3C1—Gene Expression—VDR—psoriasis	6.56e-06	0.000823	CbGpPWpGaD
Fludrocortisone—AR—Gene Expression—PPARG—psoriasis	6.03e-06	0.000756	CbGpPWpGaD
Fludrocortisone—NR3C1—Gene Expression—PPARG—psoriasis	4.57e-06	0.000574	CbGpPWpGaD
